PHYSIOMICS (LSE:PYC)

0.1600
Today's low: 0.1700
Sell PYC
0.1800
Today's high: 0.1800
Buy PYC
Last trade:
0.1700
Change:
 -0.0050 (-2.86%)
Volume:
5,829,323
Delayed price:
16:30:01
SEAQ
GBX

News

Latest News

Physiomics raises up to £562,500

Physiomics has raised up to 562,500 through the issue of new equity at 0.18p per new ordinary share and the execution of an equity swap agreement, both of which have been entered into with YA Global Master SPV. YAGM has subscribed for a total of 312,500,000 new ordinary shares at 0.18p per share for a gross consideration of 562,500.

Issue of Equity

RNS Number : 2463N Physiomics PLC 24 July 2014 Physiomics plc (Physiomics) or (the Company) Issue of Equity Execution of Equity Swap Agreement Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, announces it has raised up to 562,500 through an issue of new equity at 0.18p per New Ordinary Share and the execution of an Equity Swap Agreement, both of which have been entered into with YA Global Master SPV, Ltd. ...

Holding(s) in Company

RNS Number : 5980K Physiomics PLC 26 June 2014 Physiomics plc (Physiomics) or (the Company) Notice of Shareholding Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, received notice that following an acquisition of shares on 24 June 2014 Peter Hoskins now holds, through Barclays Nominees, 70,750,000 ordinary shares representing 4.115% of the total issued share capital of the Company. Enquiries: Physiomics plc Mark ...

All News

DateHeadlineSource
24-07-2014Issue of EquityRNS
26-06-2014Holding(s) in CompanyRNS
12-06-2014Anticipated new collaboration with DiatechRNS
20-05-2014Holding(s) in CompanyRNS
10-04-2014Second validation of Virtual Tumour ClinicalRNS
03-04-2014Virtual Tumour Clinical ValidationRNS
14-02-2014Half Yearly ReportRNS
30-01-2014Issue of Equity - ReplacementRNS
30-01-2014Issue of EquityRNS
16-01-2014Dundee University CollaborationRNS
17-12-2013Result of AGMRNS
04-12-2013Virtual Tumour ProposalRNS
28-11-2013DrugCARD launchRNS
15-11-2013Final ResultsRNS
11-11-2013University of Oxford CollaborationRNS
04-11-2013Update on the Virtual Tumour Clinical platformRNS
10-10-2013Drawdown pursuant to SEDA Arrngmnt/Issue of EquityRNS
07-10-2013Physiomics gains new speciality pharma customerRNS
01-10-2013Physiomics gains first large pharma customerRNS
16-09-2013Physiomics to present cardiac toxicity platformRNS
26-07-2013Issue of EquityRNS
01-07-2013Additional SEDA DrawdownRNS
24-06-2013Wins Poster AwardRNS
20-06-2013Award of GrantRNS
11-06-2013Population Approach Group EuropeRNS
06-06-2013Virtual Tumour Clinical ContractRNS
08-04-2013Physiomics to present new developmentsRNS
25-03-2013Physiomics to provide cardiac toxicity modellingRNS
18-03-2013New clinical PK/PD modelling serviceRNS
13-02-2013Issue of OptionsRNS
11-02-2013Director DeclarationRNS
08-02-2013Half Yearly ReportRNS
22-01-2013SEDA ArrangementRNS
07-01-2013Recruitment of Senior Scientist with Clinical PK/PRNS
18-12-2012French R&D Tax Credit AccreditationRNS
17-12-2012Result of AGMRNS
14-11-2012Final Results for the year ended 30 June 2012RNS
08-10-2012New US Business Development ConsultantRNS
10-08-2012New Agreement to optimise oncology combinationRNS
07-08-2012Stmnt re Share Price MovementRNS

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory